Formulation of human antibodies for treating TNF-alpha associated disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9732152
APP PUB NO 20170145087A1
SERIAL NO

15418465

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A liquid aqueous pharmaceutical formulation is described which has a high protein concentration, a pH of between about 4 and about 8, and enhanced stability.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABBVIE BIOTECHNOLOGY LTD2 CHURCH STREET CLARENDON STREET HAMILTON HM 11

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baust, Lisa Ludwigshafen, DE 27 1127
Dickes, Michael Rodersheim-Gronau, DE 28 1142
Krause, Hans-Juergen Gruenstadt, DE 48 2714

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 15, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 15, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00